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Embryonic stem (ES) cells have the ability to 
self-renew, producing daughter cells with equiva-
lent developmental potential, or to differentiate 
into more specialized cells. ES cells are derived 
from the inner cell mass of the preimplantation 
embryo and are pluripotent, as they are able to 
differentiate into cells of the three germ layers, 
both in vitro and in vivo (Evans and Kaufman, 
1981; Thomson et al., 1998). Three transcrip-
tion factors, OCT4, SOX2, and NANOG, coop-
erate to ensure the self-renewal and pluripotency 
of ES cells (Boyer et al., 2005; Loh et al., 2006). 
These factors are highly expressed in undiffer-
entiated ES cells and physically interact with each 
other in large protein complexes (Wang et al., 
2006; van den Berg et al., 2010). OCT4, SOX2, 
and  NANOG  are  transcriptionally  intercon-
nected and co-occupy promoters of actively tran-
scribed genes that promote ES cell self-renewal 
such as KLF4 (Boyer et al., 2005; Loh et al., 
2006; Kim et al., 2008). They also occupy genes 
encoding a large set of developmental regula-
tors that are silent in ES cells, but whose ex-
pression is associated with lineage commitment 
and cellular differentiation (Fig. 1; Boyer et al., 
2005; Loh et al., 2006).
The fact that the three key regulators can acti-
vate some genes and repress others is thought 
to be caused by the chromatin packaging in   
ES cells that are regulated by epigenetic factors. 
Epigenetics refers to heritable changes in gene 
expression that are independent of nucleo-
tide sequence. This is achieved by regulating 
gene activity through alterations of chromatin 
structure, such as posttranslational modifica-
tions of the histones and DNA methylation, 
which can be either permissive or restrictive 
for transcription. These changes are catalyzed 
by histone and DNA modification enzymes 
that work in coordination to coregulate the 
balance between pluripotency and lineage- 
specific differentiation. The question is how   
these multiple regulatory mechanisms are co-
ordinated to control the transcriptional state 
of pluripotent versus developmental genes in 
ES cells and during in vitro differentiation of 
ES cells. In this Review, we describe recent ad-
vances in the understanding of the role of the 
repressive epigenetic marks deposited by Poly-
comb group (PcG) repressive complexes and 
DNA methyl transferases (DNMTs) on ES cell 
self-renewal and differentiation.
PcG proteins in ES cells
Genome-wide approaches revealed that the tran-
scriptionally silent developmental genes targeted 
by OCT4, SOX2, and NANOG in ES cells are 
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Embryonic stem (ES) cells are derived from the inner cell mass of the preimplantation 
embryo and are pluripotent, as they are able to differentiate into all cell types of the adult 
organism. Once established, the pluripotent ES cells can be maintained under defined 
culture conditions, but can also be induced rapidly to differentiate. Maintaining this bal-
ance of stability versus plasticity is a challenge, and extensive studies in recent years have 
focused on understanding the contributions of transcription factors and epigenetic enzymes 
to the “stemness” properties of these cells. Identifying the molecular switches that regulate 
ES cell self-renewal versus differentiation can provide insights into the nature of the 
pluripotent state and enhance the potential use of these cells in therapeutic applications. 
Here, we review the latest models for how changes in chromatin methylation can modulate 
ES cell fate, focusing on two major repressive pathways, Polycomb group (PcG) repressive 
complexes and promoter DNA methylation.
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first six months after the publication date (see http://www.rupress.org/terms). 
After six months it is available under a Creative Commons License (Attribution– 
Noncommercial–Share Alike 3.0 Unported license, as described at http://creative-
commons.org/licenses/by-nc-sa/3.0/).
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ES  cells  do  not 
differentiate  ef-
ficiently into the 
three germ layers, 
they can still con-
tribute  to  their 
formation, in vivo and in vitro (Pasini et al., 2007; Chamberlain 
et al., 2008b; Leeb et al., 2010). However, loss of individual 
PRC components in ES cells does lead to marginally in-
creased expression of various lineage-affiliated genes and un-
scheduled differentiation (Morin-Kensicki et al., 2001; Pasini 
et al., 2007; Chamberlain et al., 2008b), an effect that is even 
more pronounced in ES cells carrying targeted deletions of 
both PRC1 and PRC2 genes (Leeb et al., 2010).
Genome-wide studies of PRC1 and PRC2 in ES cells 
have shown that they target promoters of >2,000 genes, of 
which a large subset overlaps with target genes of OCT4, 
NANOG, and SOX2 (Boyer et al., 2006; Lee et al., 2006). 
Further studies on the chromatin landscape in ES cells revealed 
that virtually all of these sites of PcG activity contain large re-
gions of the repressive H3K27me3 modification and are strongly 
enriched in the activation-associated H3 lysine 4 trimethyl-
ation (H3K4me3) mark around the transcriptional start site 
(Bernstein et al., 2006; Guenther et al., 2007; Mikkelsen et al., 
2007; Zhao et al., 2007). This mark is mediated through the 
SETD1 and/or MLL methyltransferase complexes (Miller et al., 
2001; Roguev et al., 2001; Milne et al., 2002; Nagy et al., 
2002), which are chromatin-activating factors that generally 
antagonize PcG silencing.
These genomic regions with opposing modifications have 
been termed “bivalent domains” and are proposed to silence 
developmental regulators while keeping them “poised.” Bi-
valent domains are not, however, exclusive to pluripotent 
cells; they can also be found in cells of restricted potency, in-
cluding T cells and fibroblasts, where genes are unlikely to be 
poised in preparation for subsequent activation (Roh et al., 
2006; Barski et al., 2007; Mikkelsen et al., 2007; Pan et al., 
2007; Zhao et al., 2007; Cui et al., 2009). However, whether 
bivalent domains are functionally important is thus far not 
known. Genes carrying H3K4me3 modifications are highly 
common among ES cells and T cells, whereas H3K27me3 
modification patterns do not overlap between ES cells and   
T cells (Zhao et al., 2007), indicating that PcG-mediated his-
tone methylations show a higher level of tissue specificity 
than H3K4me3 marks. Interestingly, recent data indicate that 
also occupied by PcG repressive complexes (Boyer et al., 
2006; Lee et al., 2006). PcG proteins facilitate maintenance 
of cell states through gene silencing and were first identified 
in Drosophila as a result of their essential roles as repressors   
of body patterning genes, including homeobox (HOX) genes 
during fruit fly development (Lewis, 1978; Struhl, 1981). 
HOX genes are expressed in distinct domains along the body 
axis and act to give cells of diverse tissues their unified re-
gional cell identities.
PcG proteins act as multimers in two main protein com-
plexes, Polycomb repressive complex 1 (PRC1) and PRC2, 
which are discriminated according to their biochemical func-
tions and compositions. The three PcG proteins EED, SUZ12, 
and EZH2 are part of PRC2, which catalyzes di- and tri-
methylation of histone H3 lysine 27 (H3K27me2/me3; 
Czermin et al., 2002; Kuzmichev et al., 2002; Müller et al., 
2002). Although the direct function of H3K27me3 is not 
fully understood, the modification correlates with transcrip-
tional repression, and it can function as a docking site for 
PRC1, which catalyzes the monoubiquitinylation of histone 
H2A at lysine 119 (H2AK119Ub1; Cao et al., 2002; Min et al., 
2003; de Napoles et al., 2004). In vitro studies suggested that 
H2AK119Ub1 blocks RNA polymerase II activity, thereby 
leading to transcriptional repression (Stock et al., 2007). Inter-
estingly, the mechanism by which PRC1 represses transcrip-
tion does not involve a block of RNA polymerase II recruitment 
to target genes, but rather attenuation of RNA polymerase II 
elongation (Stock et al., 2007). The H3K27me3 mark can 
also attract PRC2 itself, and the H3K27me3 mark is herita-
bly transmitted to daughter cells as a self-perpetuating mark 
to maintain specific gene expression programs (Hansen et al., 
2008; Margueron et al., 2009). Additionally, both PRC1 and 
PRC2 can mediate repression by direct chromatin compac-
tion as a result of alternative subunit compositions (Francis   
et al., 2004; Margueron et al., 2008; Eskeland et al., 2010), 
and PRC1-mediated H2AK119Ub1 can occur in the absence 
of H3K27me3 (Leeb et al., 2010), suggesting several alter-
native mechanisms leading to PcG-mediated repression.
The PcG proteins are required for early mammalian embryo 
development (O’Carroll et al., 2001; Wang et al., 2002; Voncken 
et al., 2003; Pasini et al., 2004), but not for maintaining 
ES cell pluripotency. PcG mutant ES cells can still self-renew, 
maintain normal morphology, and express OCT4, SOX2,   
and NANOG (Pasini et al., 2007; Chamberlain et al., 2008a; 
Leeb et al., 2010). Moreover, although the PcG knockout   
Figure 1.  ES cell self-renewal and differen-
tiation. ES cells have the ability to self-renew or 
differentiate into cells of all three germ layers 
(endoderm, ectoderm, and mesoderm). In ES cells, 
OCT4, SOX2, and NANOG form a core transcrip-
tional network influencing the stem cell self-
renewal machinery. Several hundred target  
genes co-occupied by OCT4, SOX2, and NANOG 
can be classified into two groups of downstream 
genes exerting opposing functions. One group 
includes actively transcribed genes associated 
with proliferation and transcription factors nec-
essary to maintain the ES cell state. The other 
group includes transcriptionally silent genes en-
coding developmental regulators that are only 
activated as cells differentiate and commit to 
particular lineages.JEM VOL. 207, October 25, 2010  2289
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In embryonic carcinoma cells undergoing differentiation, the 
removal of the H3K27me3 mark to permit the activation of 
gene expression is associated with recruitment of the UTX 
histone demethylase to promoters during the transcriptional 
activation (Agger et al., 2007). Interestingly, UTX is associ-
ated with the H3K4 methyltransferases MLL2–4, whereas 
JMJD3 has not been reported to bind to any of the MLL 
proteins or the H3K4 methyltransferase SETD1 (Agger et al., 
2007; Cho et al., 2007; Issaeva et al., 2007; Lee et al., 2007a). 
In a similar fashion, PRC2 can interact with and recruit a his-
tone H3K4 demethylase (Pasini et al., 2008), thereby coordi-
nating the removal of an “active” mark with the deposition 
of a repressive mark.
Importantly, PcG proteins are also recruited to promoters 
of non–ES cell–specified PcG target genes in response to dif-
ferentiation signals, and this recruitment is required for the 
silencing of these genes during differentiation (Pasini et al., 
2007; Mohn et al., 2008; Oktaba et al., 2008; Ezhkova et al., 
2009). Moreover, some ES cell–specific genes such as NANOG 
are marked by H3K27me3 during differentiation (Pan et al., 
2007; Hawkins et al., 2010). This means that when cell line-
age commitment occurs, pluripotency transcription factors 
are silenced, whereas the appropriate regulators of develop-
ment lose PcG-mediated repression and are activated (Fig. 2). 
By this mechanism, which reduces the likelihood of inappro-
priate reactivation of stem cell–specific or lineage-unrelated 
genes, the PcG repressive complexes are believed to contrib-
ute to the robustness of differentiation. In support of this view, 
PcG-deficient ES cells can enter differentiation, but fail to 
maintain the differentiated phenotype (Pasini et al., 2007; 
Leeb et al., 2010).
A key question of importance for ES cell self-renewal and 
differentiation is how PcG binding to chromatin is regulated 
the presence of H3K4me3 mark might not itself be indicative 
or predictive of transcriptional activity (Guenther et al., 
2007), and that the H3K4me3 mark is found on genes in the 
absence of sequence-specific activators in ES cells and with-
out the stable association of RNA polymerase II (Thomson 
et al., 2010; Vastenhouw et al., 2010); thus, the significance 
of genome-wide marking of promoters by H3K4me3 is not 
clear at this moment. This means that the ability of the biva-
lent mark to silence lineage-specific gene expression is likely 
caused by the dominant effect of the H3K27me3 over the 
H3K4me3 mark, yet preserves the potential for rapid gene 
activation upon differentiation of stimuli-induced removal of 
the H3K27me3 mark.
Cell fate specifications in mammals permit the formation 
of 200 different cell types consistent with a multitude of 
different combinations of the epigenome in mammalian de-
velopment. ES cellular differentiation entails loss of pluripo-
tency and parallel gain of first lineage-specific and, ultimately, 
cell-type specific characteristics. The process of tissue fate spe-
cification is initiated by signaling molecules that drive the dy-
namic equilibrium of ES cells toward a particular lineage.
As some results suggest that the repressive H3K27me3 
mark can be heritably transmitted to daughter cells to main-
tain specific gene expression programs (Hansen et al., 2008; 
Margueron et al., 2009), the expression of developmentally 
regulated genes would require the removal of the H3K27me3 
mark. The UTX and JMJD3 genes encode H3K27me3/me2 
demethylases, suggesting a mechanism by which PcG-repressed 
promoters are activated (Agger et al., 2007; De Santa et al., 
2007; Lan et al., 2007; Lee et al., 2007b). For example, UTX 
is absent from the transcriptionally silent HOXA9 gene pro-
moter in ES cells, but is present in this region in primary fi-
broblasts, in which HOXA9 gene is expressed (Lan et al., 2007). 
Figure 2.  Dynamic recruitment of PcG  
proteins to chromatin during lineage specifi-
cation. In ES cells, differentiation and develop-
ment-promoting genes (Dev. A, B, and C) are 
repressed by bivalent domains, whereas late dif-
ferentiation genes are not marked by H3K27me3, 
but not expressed. Pluripotency genes such as 
OCT4 are methylated at H3K4 and expressed. 
Differentiation signals generate cells committed 
to various somatic lineages, and activate lineage-
specific genes that lose the repressive H3K27me3 
mark (Dev. A). However, many genes preserve the 
bivalent domains and are not expressed (Dev.  
B and C); a few of these genes (e.g., those that are 
selectively expressed in other somatic cell line-
ages) also gain promoter DNA methylation  
during lineage commitment to ensure silencing 
(Dev. C). Late differentiation genes become 
marked by H3K27 in a manner dependent on the 
particular committed cell type, resulting in the formation of new bivalent domains that may be resolved in more mature differentiated cells. Examples of 
the aforementioned dynamics during neuronal differentiation of ES cells are NEUROG1, encoding for a neurogenic transcription factor (Dev. A); GATA4, 
encoding for an endodermal marker (Dev. B); TPARP, encoding for a germline-specific polyadenylate polymerase (Dev. C); and SCN1B, encoding for a  
neuronal voltage-gated sodium channel (late diff. gene; Mohn et al., 2008). The population of de novo DNA-methylated genes is also enriched in  
pluripotency-specific genes such as OCT4, ensuring the stable repression of transcripts that are required for ES cell maintenance.2290 Epigenetic state in ES cells | Christophersen and Helin
JARID2 is unusual among the JmjC proteins in that it lacks 
crucial residues for cofactor binding and is catalytically inac-
tive (Cloos et al., 2008). JARID2, which can bind directly to 
DNA,  cofractions  with  PRC2  in  high  molecular  weight 
complexes, and localization of PRC2 to its respective target 
sites is dependent on JARID2. It remains unclear whether 
JARID2 regulates the intrinsic histone methyltransferase activity 
of the PRC2 complex because the five different studies reached 
different conclusions on this point and major global reduc-
tions in H3K27me3 levels were not detected in ES cells lack-
ing JARID2. Importantly, however, JARID2 was shown to 
be required for the execution of differentiation pathways in 
ES cells (Shen et al., 2009; Landeira et al., 2010; Li et al., 
2010; Pasini et al., 2010). In addition to lack of recruitment 
of PRC2, this effect might be caused by a role of JARID2 in 
recruiting PRC1 and poised RNA polymerase II to PcG target 
genes (Landeira et al., 2010).
PRC2 also interacts with the protein MTF2 (also named 
PCL2; Shen et al., 2009; Li et al., 2010). MTF2 is one of three 
mammalian homologues of Drosophila Polycomb-like, which 
can stimulate PRC2 activity in Drosophila (Nekrasov et al., 
2007). Interestingly, MTF2 was recently found in a screen for 
novel regulators of ES cell self-renewal and shown to be in-
volved in recruiting PRC2 to a subset of PcG target genes in 
ES cells (Walker et al., 2010). Whether JARID2 and MTF2 
are both found in a subset of PRC2 complexes is unclear, but 
coimmunoprecipitation  studies  indicate  that  JARID2  and 
MTF2 can reside in distinct PCR2 subcomplexes. These results 
highlight the importance of dissecting the composition and 
activities of different PRC2 complexes and their associated 
“recruiters” to fully understand how PcG proteins control 
thousands of genes in many different cellular and develop-
mental contexts. For example, JARID2 expression declines 
rapidly as ES cells differentiate (Boyer et al., 2005), and other 
proteins must therefore regulate recruitment of PRC2 to target 
genes during differentiation. Strong candidates for this include 
to ensure proper PcG recruitment to and dissociation from 
chromatin. Because the PcG proteins themselves do not have 
the ability to bind DNA-specific sites, recruitment is believed 
to require the interaction with sequence-specific transcrip-
tion factors. The availability of these transcription factors or 
competing transcription factors may be involved in regulat-
ing  the  sustained  binding  of  PcG  proteins  to  their  target 
genes. In Drosophila, the PcG proteins are recruited to Poly-
comb repressive elements (PREs). These elements are stretches 
of DNA of >1,000 bp containing DNA-binding sites for dif-
ferent transcription factors. Several Drosophila transcription 
factors have been shown to bind to the PREs and to be re-
quired for the recruitment of the Drosophila PcG proteins to 
target genes. Importantly, however, the results obtained so far 
suggest that no single transcription factor is sufficient to recruit 
the PcG proteins, but that a combination of transcription fac-
tors is required. Moreover, only one of the PRE-associated 
Drosophila transcription factors is conserved in mammalian 
cells (YY1 in mammals, PHO in Drosophila), and YY1 binding 
in mammals does not overlap with PcG target genes (Squazzo 
et al., 2006).
PREs have not been mapped in mammalian cells, despite 
genome-wide PRC-binding maps (Boyer et al., 2006; Bracken 
et al., 2006; Lee et al., 2006), though a region between two 
HOX genes might target PcG proteins to a reporter gene in 
human cells (Woo et al., 2010). In addition to YY1, it has been 
speculated that OCT4 could be involved in PcG recruitment 
(Wang et al., 2006; van den Berg et al., 2010), though these 
studies have not been independently confirmed.
Recent results have, however, shed new light on PcG 
protein recruitment in ES cells (Fig. 3). Five independent 
studies identified the Jumonji C (JmjC) protein JARID2 as a 
novel component of PRC2, displaying a significant overlap 
with PRC2 target sites in ES cells (Peng et al., 2009; Shen et al., 
2009; Landeira et al., 2010; Li et al., 2010; Pasini et al., 2010). 
JmjC domains are characteristic of lysine demethylases, but 
Figure 3.  Potential mechanisms of PRC2 
recruitment to target genes. PRC2 is recruited 
to target genes by a combination of transcription 
factors and ncRNAs. A fraction of PRC2 associ-
ates with JARID2, which is required for PRC2 
binding to its target genes in ES cells. JARID2 
might therefore represent a core component of 
PRC2 in ES cells, although other PRC2 complexes 
exist; these contain MTF2, PHF1, and other un-
characterized factors that could represent alter-
native targeting mechanisms operative both 
during ES cell self-renewal and differentiation. 
Sequence-specific transcription factors (TF) and 
ncRNA might also recruit the PRC2 core complex 
to target genes during differentiation. Finally, PcG 
target genes are CpG-rich, and proteins binding 
to CpG elements such as TET1 or the histone 
demethylase FBXL10 might have a role in recruit-
ing Polycomb to target genes. For additional in-
formation on the components of PRC1 and PRC2 
complexes, see Morey and Helin (2010).JEM VOL. 207, October 25, 2010  2291
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associate  with  nucleosomes  carrying  the  H3K4me3  mark. 
Some of these regulate constitutively expressed housekeeping 
genes, but others corresponding to developmental regulators 
also contain the H3K27me3 mark. This observation raises the 
question of why these poised, yet inactive, CpG-rich pro-
moters are protected from DNA methylation. Recent data 
showed that the CPF1 protein has affinity for nonmethylated 
CpG islands, and because CPF1 associates with the H3K4 
methyltransferase SETD1 it leads to H3K4 trimethylation   
of CpG-rich promoters (Thomson et al., 2010). As some 
DNMT domain–containing proteins bind to unmethylated, 
but not methylated, H3K4 and recruit DNMTs (Ooi et al., 
2007), this SETD1-induced H3K4 methylation may protect 
both active and inactive CpG-rich promoters from DNA 
methylation.  Methylated  low  CpG  promoters  are  marked 
neither by H3K4me3 nor by H3K27me3 and are mostly re-
pressed in ES cells (Fouse et al., 2008; Meissner et al., 2008; 
Mohn et al., 2008).
The conversion of ES cells into somatic cells only leads to 
modest changes in DNA methylation at promoter regions 
and the majority of promoters maintain their methylation 
levels during differentiation (Lagarkova et al., 2006; Fouse   
et al., 2008; Meissner et al., 2008; Mohn et al., 2008; Hawkins 
et al., 2010). These observations question the importance of 
DNA methylation as a controlling element of cellular differ-
entiation. However, a small number of genes do become 
methylated during development, an event that is accompa-
nied  by  silencing  of  the  associated  promoters  (Lagarkova   
et al., 2006; Fouse et al., 2008; Meissner et al., 2008; Mohn 
et al., 2008; Hawkins et al., 2010). Many of the identified 
targets of differentiation-coupled de novo methylation are 
promoters of stem cell–specific genes, including those encod-
ing pluripotency transcription factors (Lagarkova et al., 2006; 
Fouse et al., 2008; Meissner et al., 2008; Mohn et al., 2008; 
Hawkins et al., 2010). DNA methylation is thought to keep 
such genes silent in differentiated cells and prevent their aber-
rant reactivation and the risk of de-differentiation (Fig. 2).   
In line with this hypothesis, in vitro differentiation of DNMT 
mutant ES cells leads to rapid apoptotic cell death (Panning 
and Jaenisch, 1996), reflecting the importance of DNA methyl-
ation in differentiated cells, which is also described for other 
cell types (Jackson-Grusby et al., 2001).
As a consequence it is a prerequisite that some promoters 
of stem cell genes are demethylated during reprogramming to 
enable reacquisition of pluripotency (Simonsson and Gurdon, 
2004; Takahashi and Yamanaka, 2006). This demethylation 
may occur through a DNA repair process (Bhutani et al., 2010; 
Hajkova et al., 2010), or involve the recently isolated enzymes 
of the TET family that can convert methylated cytosine to 
hydroxymethylated cytosine (Tahiliani et al., 2009).
Concluding remarks
Progress in the past few years has greatly enhanced our under-
standing of epigenetic control of ES cells. Epigenetic factors 
appear to be essential for regulating cell fate decisions and 
maintaining the cellular state of differentiated cells. Surprisingly, 
PHF1/PCL1, PHF19/PCL3, AEBP2, and NIPP1, which have 
all been previously associated with PRC2 (Cao et al., 2008; 
Nuytten et al., 2008; Sarma et al., 2008; Kim et al., 2009).
Recent advances suggest that noncoding RNAs (ncRNAs) 
also play a role in the recruitment of PcG complexes in ES 
cells. DNA microarray analysis showed that short ncRNAs 
(<200 nt) were transcribed from the 5 end of several hundred 
PcG target genes in ES cells (Kanhere et al., 2010). Interest-
ingly, these ncRNAs interact with PRC2 and are involved in 
stabilizing PRC2 association with chromatin. Moreover, the 
ncRNAs were depleted from PcG target genes that are de-
repressed during cell differentiation (Kanhere et al., 2010). This 
indicates that short ncRNAs might function as the interface 
between DNA and specific chromatin remodeling activities, 
though the importance of direct base pairing at specific sequence 
motifs is still unknown. Long ncRNAs (lincRNAs; transcripts 
longer than 200 nt) have also been reported to recruit PRC2 
to specific targets, including the HOXD cluster and the inac-
tive X chromosome (Rinn et al., 2007; Pandey et al., 2008; 
Zhao et al., 2008). In addition, lincRNAs are now emerging 
as a new class of noncoding transcripts, with >3,000 members of 
which 20% might associate with PRC2 (Guttman et al., 2009; 
Khalil et al., 2009). Importantly, lincRNAs show dynamic 
patterns of expression with suggested roles in cell fate choices, 
but the mechanisms by which these trans-acting ncRNAs   
recruit PcG complexes to specific sites is not fully understood. 
Interestingly, the lincRNA HOTAIR was recently shown   
to target both PRC2 and the H3K4me2 demethylase LSD1 
to hundreds of genes thereby acting as a modular scaffold   
(Tsai et al., 2010).
Collectively, these studies demonstrate that both DNA-
binding factors and ncRNAs can guide de novo histone 
modification by PcG proteins and establish repressive chro-
matin domains.
DNA methylation in ES cells
A second major repressive epigenetic pathway is mediated by 
DNMTs. Methylation of cytosine residues in CpG dinucleo-
tides in promoter regions catalyzed by DNMTs is an impor-
tant epigenetic mark that maintains long-term repression by 
controlling DNA accessibility (Bird, 2002). DNMTs are es-
sential  for  embryonic  development  (Okano  et  al.,  1999), 
whereas they are not required for self-renewal or genomic 
integrity of ES cells (Tsumura et al., 2006). This probably re-
flects the fact that blastocysts undergo global demethylation 
immediately before the derivation of ES cells from blastocysts 
(Mayer et al., 2000).
Promoters can be classified according to whether they 
contain high or low CpG content within a certain region around 
the transcriptional start sites. These distinct promoter classes 
show differences in their methylation levels and in the mech-
anisms through which they are regulated. In ES cells, high 
CpG promoters have low DNA methylation levels, whereas 
low CpG promoters have relatively high DNA methylation 
levels (Fouse et al., 2008; Meissner et al., 2008; Mohn et al., 
2008). CpG-rich promoters—almost by default—appear to   2292 Epigenetic state in ES cells | Christophersen and Helin
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regulation may be dispensable for maintaining ES cell identity. 
Epigenetic mechanisms of gene silencing contribute to the 
overall stability of pluripotency, but are downstream in this 
setting. Thus, ES cell identity might primarily be regulated 
by transcription factors, whereas epigenetic chromatin-based 
repressive and activating modifiers may serve transcriptional 
corepressor and co-activating functions in this process. Never-
theless, the stability of a given cell state relies on the silencing 
of genes encoding inducers of other cell states. For example, 
expression of only a few transcription factors that produce 
cell type–specific gene expression programs can cause cells to 
adopt new states (Vierbuchen et al., 2010). By setting thresh-
olds, PcG proteins may help prevent inappropriate gene ex-
pression induced by weak activating signals and thereby limit 
noise-induced errors and neutralize extrinsic perturbations. 
DNA methylation is used to lower the chance of spurious 
activation, which is more likely to occur in a bivalent chro-
matin environment.
Our understanding of how different regulatory networks 
are activated to guide lineage commitment is still limited. For 
example, the identity of differentiation signals that lead to se-
lective activation of genes encoding specific developmental 
regulators by turning off PcG repression and recruiting UTX 
or JMD3 remains unknown. Moreover, mechanisms of re-
cruiting PcG proteins to PcG targets in a developmental stage-
specific context by transcription factors remain to be dissected. 
Further characterization of epigenetic regulation will help to 
provide a more comprehensive view of the molecular mech-
anisms that govern the balance between self-renewal and 
lineage commitment. This advance may lead to improved 
protocols for directing the differentiation of ES cells toward 
particular lineages and for the generation of ES-like cells from 
somatic cells.
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